Business Wire

Thales Wins Google Cloud Technology Partner of the Year Security – Data Protection Award

29.8.2023 17:00:00 EEST | Business Wire | Press release

Share

Thales has been selected as the Google Cloud Technology Partner of the Year in the Security – Data Protection category. Thales was selected alongside a global field of top Google Cloud partners for excellence in developing and implementing customer solutions based on Google Cloud’s technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230829348216/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

©Thales

The Thales and Google Cloud collaboration addresses the needs of organizations around the world that are facing ever-increasing security, sovereignty, and performance requirements for their cloud deployments. With many years of cybersecurity expertise, Thales provides the level of trust and security required for customers around the world to move to the cloud, while maintaining the necessary level of control. By combining Thales’ platform expertise with Google Cloud’s enterprise-grade solutions and cutting-edge infrastructure, the two companies work closely on a number of broad data security initiatives.

Thales, in its constant search of excellence in its security portfolio, recently announced a new collaboration to develop data security capabilities and bring additional AI-powered features to users of its CipherTrust Data Security platform. This is powered by Google Cloud’s Vertex AI machine learning capabilities, to discover, classify and protect sensitive data in the cloud. The machine learning functionality helps to automate fundamental tasks for customers and ensure their sensitive cloud-hosted data remains protected.

Since late 2022, Thales’ CipherTrust Cloud Key Manager has also supported Bring Your Own Key (BYOK) initiatives, including those for Google Cloud and Google Workspace. Thales and Google Cloud have also collaborated to operate a sovereign cloud joint venture (S3NS) for Google Cloud customers in France who seek to meet stringent data sovereignty requirements, such as those applicable to state and critical infrastructure organizations.

Thales has built a structured cloud offering for companies that want to meet the most demanding data protection standards. In France, S3NS, the joint venture between Thales and Google Cloud, aims to offer French companies and public institutions a solution providing the equivalent of Google Cloud , compliant with the “SecNumCloud” label, a certification from the French information systems security agency (ANSSI). To date, SecNumCloud has the highest level of protection in France, excluding the protection of national defense secrets, and in Europe. S3NS has a first offering already available that offers additional guarantees & controls, such as data location in Europe and external encryption managed by S3NS (based on Thales technology).

“Google Cloud’s partner awards recognize the significant impact and customer success that our partners have driven over the past year," said Kevin Ichhpurani, Corporate Vice President, Global Ecosystem and Channels at Google Cloud. "We're delighted to recognize Thales as a 2023 Google Cloud Partner Award winner, and look forward to a continued strong partnership in support of our mutual customers."

Sebastien Cano, Senior Vice President of Cloud Protection and Licensing activities at Thales, commented: “We are very proud of our ongoing relationship with Google Cloud and this latest award recognises the brilliant work we’ve been doing with them across a range of projects. Together we are helping customers around the world discover, classify and protect their data more efficiently, and ensure their move to the cloud is as secure and compliant as possible.”

Thales is also participating at Google Cloud Next, which is taking place from 29-31 August 2023. Some of the sessions include:

How global leaders are addressing digital sovereignty requirements, with Cyprien Falque, CEO of S3NS More details about the event, which will be available to watch both live and on-demand online, can be found here.

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies within three domains: Defence & Security, Aeronautics & Space, and Digital Identity & Security. It develops products and solutions that help make the world safer, greener and more inclusive.

 

The Group invests close to €4 billion a year in Research & Development, particularly in key areas such as quantum technologies, Edge computing, 6G and cybersecurity.

 

Thales has 77,000 employees in 68 countries. In 2022, the Group generated sales of €17.6 billion.

 

PLEASE VISIT

Thales Group
Cloud Protection & Licensing Solutions | Thales Group

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS CONTACT
Thales, Media Relations
Security & Cybersecurity
Marion Bonnet
+33 (0)6 60 38 48 92
marion.bonnet@thalesgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release

With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye